This study investigated the relationship between gamma-glutamyltransferase/alanine aminotransferase (GGT/ALT) ratio and carotid plaques in patients with coronary artery disease (CAD). This multicenter retrospective study included 8,255 patients with CAD who were divided according to GGT/ALT quartiles: Q1 (GGT/ALT ≤ 1.00), Q2 (1.00 < GGT/ALT ≤ 1.41), Q3 (1.41 < GGT/ALT ≤ 2.05), and Q4 (GGT/ALT > 2.05). Logistic regression was used to analyze the relationship between GGT/ALT, carotid plaques, and carotid plaque echogenicity. GGT/ALT ratio (odds ratio [OR]: 1.16; 95% confidence interval [CI]: 1.11–1.21; P < .001) was significantly associated with carotid plaque risk. The degree of relevance was higher in men (OR: 1.71; 95% CI: 1.35–2.15; P < .001) than in women (OR: 1.56; 95% CI: 1.28–1.91; P < .001). The ORs value of carotid plaque risk was higher in middle-aged patients (OR: 2.23; 95% CI: 1.78–2.80; P < .001) than in older patients (OR: 1.77; 95% CI: 1.44–2.18; P < .001). The GGT/ALT ratio was significantly associated with different carotid plaque echogenicity, and the highest OR values were for isoechoic plaques (OR: 1.18; 95% CI: 1.12–1.24; P < .001). These findings suggest that the GGT/ALT ratio might be associated with a high risk of developing carotid plaques and different types of plaque echoes and was more significantly associated with isoechoic plaques.
BosDArshiBvan den BouwhuijsenQJA, et al.Atherosclerotic carotid plaque composition and incident stroke and coronary events. J Am Coll Cardiol. 2021;77(11):1426-1435.
2.
BenjaminEJViraniSSCallawayCW, et al.Heart disease and stroke statistics-2018 update: A report from the American heart association. Circulation. 2018;137(12):e67-e492.
3.
HirataTAraiYTakayamaM, et al.Carotid plaque score and risk of cardiovascular mortality in the oldest old: results from the TOOTH study. J Atheroscler Thromb. 2018;25(1):55-64.
4.
KinoshitaKToshikuniNSaitoT, et al.The combination of fatty liver and increased gamma-glutamyl transpeptidase levels as a risk factor for atherosclerotic plaque development in apparently healthy people. Turk J Med Sci. 2019;49(5):1350-1357.
5.
RahmaniJMiriANamjooI, et al.Elevated liver enzymes and cardiovascular mortality: A systematic review and dose-response meta-analysis of more than one million participants. Eur J Gastroenterol Hepatol. 2019;31:555-562.
6.
KunutsorSKApekeyTAKhanH. Liver enzymes and risk of cardiovascular disease in the general population: A meta-analysis of prospective cohort studies. Atherosclerosis. 2014;236(1):7-17.
7.
ZhaoZZhuYNiX, et al.Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC. Cancer Cell Int. 2021;21(1):517.
8.
ZhangQJiaoX. LDH and GGT/ALT Ratio as novel prognostic biomarkers in hepatocellular carcinoma patients after liver transplantation. Comput Math Methods Med. 2021;2021:9809990.
9.
JuMJQiuSJFanJ, et al.Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation. J Gastroenterol. 2009;44(6):635-642.
10.
Van BeekJHde MoorMHde GeusEJ, et al.The genetic architecture of liver enzyme levels: GGT, ALT and AST. Behav Genet. 2013;43(4):329-339.
11.
Serra-PlanasEAguileraECastroL, et al.Low prevalence of non-alcoholic fatty liver disease in patients with type 1 diabetes is associated with decreased subclinical cardiovascular disease. J Diabetes. 2017;9(12):1065-1072.
12.
PatelDASrinivasanSRXuJH, et al.Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study. Metabolism. 2007;56(6):792-798.
13.
NdrepepaGColleranRKastratiA. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary artery disease. Clin Chim Acta. 2018;476:130-138.
14.
UngerTBorghiCCharcharF, et al.2020International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-1357.
15.
American Diabetes Association 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13-S28.
16.
YangLLiZSongY, et al.Study on urine metabolic profiling and pathogenesis of hyperlipidemia. Clin Chim Acta. 2019;495:365-373.
17.
XingDMZhuMJLiuCX, et al.Outcome measures in clinical trials of traditional Chinese medicine for stable angina pectoris. Acupunct Herb Med. 2021;1(2):99-106.
18.
ChalasaniNYounossiZLavineJE, et al.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357.
19.
KohsariMMoradinazarMRahimiZ, et al.Liver Enzymes and Their Association with Some Cardiometabolic Diseases: Evidence from a Large Kurdish Cohort. BioMed Res Int. 2021;2021:5584452.
20.
PahwaPChuLKarunanayakeC, et al.Predictive biomarkers of cardiovascular disease in adult Canadian population. J Diabetes Metab Disord. 2021;20(2):1199-1209.
21.
ZhouBZhangGGuoW, et al.Xiaoke decoction in treatment of type II diabetes: A meta-analysis. Chin Herb Med. 2022;14(1):130-141.
22.
VozarovaBStefanNLindsayRS, et al.High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51(6):1889-1895.
23.
LeeDHSilventoinenKJacobsDRJr, et al.gamma-glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women. J Clin Endocrinol Metab. 2004;89(11):5410-5414.
24.
JoSKLeeWYRheeEJ, et al.Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria. Clin Chim Acta. 2009;403(1–2):234-240.
25.
AndrePBalkauBBornC, et al.Hepatic markers and development of type 2 diabetes in middle aged men and women: A three-year follow-up study. The d.E.S.I.R. Study (data from an epidemiological study on the insulin resistance syndrome). Diabetes Metab. 2005;31(6):542-550.
26.
GodslandIFJohnstonDG. Co-associations between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology. Metabolism. 2008;57(9):1190-1197.
27.
NigroJOsmanNDartAM, et al.Insulin resistance and atherosclerosis. Endocr Rev. 2006;27(3):242-259.
28.
NakanishiNSuzukiKTataraK. Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men. Diabetes Care. 2004;27(6):1427-1432.
29.
Kazemi-ShiraziLEndlerGWinklerS, et al.Gamma glutamyltransferase and long-term survival: Is it just the liver?Clin Chem. 2007;53(5):940-946.
30.
ZengJYangRXSunC, et al.Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease. World J Gastroenterol. 2020;26:1792-1804.
GuptaAKesavabhotlaKBaradaranH, et al.Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke. 2015;46(1):91-97.
33.
MushenkovaNVSummerhillVIZhangD, et al.Current advances in the diagnostic imaging of atherosclerosis: insights into the pathophysiology of vulnerable plaque. Int J Mol Sci. 2020;21(8):2992.
34.
KomatsuTIguchiYAraiA, et al.Large but nonstenotic carotid artery plaque in patients with a history of embolic stroke of undetermined source. Stroke. 2018;49(12):3054-3056.
35.
KozakovaMPalomboCEngMP, et al.Fatty liver index, gamma-glutamyltransferase, and early carotid plaques. Hepatology. 2012;55(5):1406-1415.
36.
PucciAFranziniMMatteucciM, et al.b-Gamma-glutamyltransferase activity in human vulnerable carotid plaques. Atherosclerosis. 2014;237(1):307-313.
37.
BelcastroEFranziniMCianchettiS, et al.Monocytes/macrophages activation contributes to b-gamma-glutamyltransferase accumulation inside atherosclerotic plaques. J Transl Med. 2015;13:325.
38.
PucciASheibanIFormatoL, et al.In vivo coronary plaque histology in patients with stable and acute coronary syndromes: Relationships with hyperlipidemic status and statin treatment. Atherosclerosis. 2007;194(1):189-195.
39.
CrisbyMNordin-FredrikssonGShahPK, et al.Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001;103(7):926-933.
40.
HutchesonJDMaldonadoNAikawaE. Small entities with large impact: microcalcifications and atherosclerotic plaque vulnerability. Curr Opin Lipidol. 2014;25(5):327-332.
41.
ShioiAIkariY. Plaque calcification during atherosclerosis progression and regression. J Atheroscler Thromb. 2018;25(4):294-303.
42.
SabaLNardiVCauR, et al.Carotid artery plaque calcifications: Lessons from histopathology to diagnostic imaging. Stroke. 2022;53(1):290-297.
43.
NivukoskiUBloiguABloiguR, et al.Liver enzymes in alcohol consumers with or without binge drinking. Alcohol. 2019;78:13-19.
44.
CarterARBorgesMCBennM, et al.Combined association of body mass index and alcohol consumption with biomarkers for liver injury and incidence of liver disease: A mendelian randomization study. JAMA Netw Open. 2019;2(3):e190305.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
